Mice Ideas

Day 1 -16 July 2020
Day 2 - 17 July 2020

Day 1 - Immuno Oncology & Targeted Therapies Update 2020 - 16 July 2020

Part 1 - Introduction & Welcome - Dr Sachin Gupta, Mohali

Part 2 - Opening Remarks - Dr Ashok Vaid, Gurugram

Part 3 - Interpretating NGS, MSI-MMR, TMB: from Lab to Clinic - Dr B K Smruti, Mumbai

Part 4 - Panel Discussion - Selecting the Right Molecular Test for your patient - Dr K Govind Babu

Part 5 - Optimal Management of Mutation Negative Advanced Lung Cancer - Dr Anubha Bhartuar

Part 6 - Optimal Management of EGFR Mutation Positive Advanced Lung Cancer - Dr Shyam Aggarwal

Part 7 - ImmunoTherapy in stage 3 NSCLC/Evidence & Experience so far - Dr Kumar Prabhash, Mumbai

Part 8 - Personalised Therapy to further improve outcomes in BRAF mutated mNSCLC - Dr Ullas Batra

Part 9 - Panel Discussion Metastatic Lung Cancer - Role of Targeted Agents & Immunotherapy- Dr Ullas

Part 10 - Take Home Message - Dr Hemant Malhotra, Jaipur

Part 11- Management of Relapsed Refractory Multiple Myeloma:Noval Treatment Options- Dr Uday

Part 12 - How I Will Treat DLBCL in 2020? - Dr Rahul Bhargava, Delhi

Part 13 - Optimal Management of CLL - is there a need for chemotherapy at all? - Dr Dinesh Bhurani

Part 14 - Panel Discussion: Optimal Management of High Grade B Cell Lymphomas - Dr Deepesh Lad

Day 2 - Immuno Oncology & Targeted Therapies Update 2020 - 17 July 2020

Part 1 - Introductory Remarks - Dr Sachin Gupta, Mohali

Part 2 - Management of Treatment Naive Metastatic Hepato Cellular Carcinoma - Dr Bharat Bhosale

Part 3 - Precision Medicine for Relapsed Ovarian Cancer, Optimal use of Targeted agents - Dr Sandeep

Part 4 - Immunotherapy and Targeted Therapy in mRCC : Current Standard of Care - Dr Vineet Talwar

Part 5 - Case Based Discussion on optimal management of metastatic RCC & bladder Cancer - Dr T. Raja

Part 6 - Current status of novel agents in Hormone Refractory Prostate Cancer - Dr Niti Raizada

Part 7 - Take Home Message - Dr Purvish Parikh, Mumbai

Part 8 - Immunotherapy and Targeted therapy Update in Head and Neck Cancer - Dr Ankur Bhal, - Delhi

Part 9 - Upfront Immunotherapy in Extensive stage Small Cell Lung Cancer - Dr Vamshi Krishna M

Part 10 - Optimal Management of ER Positive Metastatic Breast Cancer - Dr Davinder Paul, Ludhiana

Part 11 - Optimal Management ER+ve - Hormone Refractory Advance Breast Cancer - Dr Jyoti Bajpai

Part 12 - Panel Discussion : ER Positive Hormone Refractory Metastatic Breast Cancer - Dr TP Sahoo

Part 13- Case Based Discussion on optimal sequencing of Anti HER2 therapies in HER2 +ve MBC- Dr Vaid

Pat 14 - Take Home Message - Dr GS Bhattacharyya - Kolkata